Open AccessDe novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort: CD5 positivity affects DLBCL outcome
Author(s) -
Lapo Alinari,
Alejandro A. Gru,
Carl Quinion,
Ying Huang,
Arletta Lozanski,
Gerard Lozanski,
Jacqueline N. Poston,
Girish Venkataraman,
Eunhye Oak,
Friederike Kreisel,
Steven I. Park,
Stephanie B. Matthews,
Jeremy S. Abramson,
Hana Lim,
P. G. Martin,
Jonathon B. Cohen,
Andrew M. Evens,
Zeina AlMansour,
Arun K. Singavi,
Timothy S. Fenske,
Kristie A. Blum
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/v7rm-tb26
Subject(s) - rituximab , medicine , diffuse large b cell lymphoma , transplantation , oncology , lymphoma , cohort